nodes	percent_of_prediction	percent_of_DWPC	metapath
Flunisolide—CYP3A4—breast cancer	0.141	1	CbGaD
Flunisolide—NR3C1—Fluoxymesterone—breast cancer	0.121	0.397	CbGbCtD
Flunisolide—Prednisone—Exemestane—breast cancer	0.0341	0.0864	CrCrCtD
Flunisolide—Fluprednidene Acetate—Exemestane—breast cancer	0.0317	0.0802	CrCrCtD
Flunisolide—Loteprednol—Exemestane—breast cancer	0.0317	0.0802	CrCrCtD
Flunisolide—Methylprednisolone—Exemestane—breast cancer	0.0296	0.075	CrCrCtD
Flunisolide—Prednisolone—Exemestane—breast cancer	0.029	0.0734	CrCrCtD
Flunisolide—CYP3A4—Exemestane—breast cancer	0.0244	0.08	CbGbCtD
Flunisolide—Amcinonide—Fluoxymesterone—breast cancer	0.0243	0.0614	CrCrCtD
Flunisolide—Desoximetasone—Fluoxymesterone—breast cancer	0.0225	0.0569	CrCrCtD
Flunisolide—Fluorometholone—Fluoxymesterone—breast cancer	0.022	0.0556	CrCrCtD
Flunisolide—Loteprednol—Fluoxymesterone—breast cancer	0.022	0.0556	CrCrCtD
Flunisolide—Fluprednidene Acetate—Fluoxymesterone—breast cancer	0.022	0.0556	CrCrCtD
Flunisolide—Mometasone—Fluoxymesterone—breast cancer	0.022	0.0556	CrCrCtD
Flunisolide—Triamcinolone—Fluoxymesterone—breast cancer	0.022	0.0556	CrCrCtD
Flunisolide—Dexamethasone—Fluoxymesterone—breast cancer	0.0215	0.0543	CrCrCtD
Flunisolide—Betamethasone—Fluoxymesterone—breast cancer	0.0215	0.0543	CrCrCtD
Flunisolide—CYP3A4—Letrozole—breast cancer	0.0208	0.068	CbGbCtD
Flunisolide—Prednisolone—Fluoxymesterone—breast cancer	0.0201	0.0509	CrCrCtD
Flunisolide—Hydrocortisone—Fluoxymesterone—breast cancer	0.0193	0.0488	CrCrCtD
Flunisolide—CYP3A4—Anastrozole—breast cancer	0.0185	0.0606	CbGbCtD
Flunisolide—CYP3A4—Toremifene—breast cancer	0.0169	0.0554	CbGbCtD
Flunisolide—CYP3A4—Fulvestrant—breast cancer	0.0157	0.0515	CbGbCtD
Flunisolide—CYP3A4—Thiotepa—breast cancer	0.014	0.0459	CbGbCtD
Flunisolide—CYP3A4—Ixabepilone—breast cancer	0.0128	0.042	CbGbCtD
Flunisolide—CYP3A4—Lapatinib—breast cancer	0.0123	0.0404	CbGbCtD
Flunisolide—CYP3A4—Raloxifene—breast cancer	0.00936	0.0307	CbGbCtD
Flunisolide—CYP3A4—Vinorelbine—breast cancer	0.00685	0.0224	CbGbCtD
Flunisolide—CYP3A4—Tamoxifen—breast cancer	0.00618	0.0203	CbGbCtD
Flunisolide—CYP3A4—Mitoxantrone—breast cancer	0.00603	0.0198	CbGbCtD
Flunisolide—CYP3A4—Paclitaxel—breast cancer	0.00481	0.0158	CbGbCtD
Flunisolide—CYP3A4—Irinotecan—breast cancer	0.00475	0.0156	CbGbCtD
Flunisolide—CYP3A4—Vinblastine—breast cancer	0.00422	0.0138	CbGbCtD
Flunisolide—CYP3A4—Docetaxel—breast cancer	0.00348	0.0114	CbGbCtD
Flunisolide—CYP3A4—Doxorubicin—breast cancer	0.00259	0.0085	CbGbCtD
Flunisolide—Fluocinolone Acetonide—PLA2G4A—breast cancer	0.000275	0.108	CrCbGaD
Flunisolide—Fluticasone Propionate—PLA2G4A—breast cancer	0.000188	0.0737	CrCbGaD
Flunisolide—Fluticasone Propionate—PGR—breast cancer	0.000124	0.0487	CrCbGaD
Flunisolide—SERPINA6—pituitary gland—breast cancer	0.000119	0.0874	CbGeAlD
Flunisolide—Betamethasone—PGR—breast cancer	0.000114	0.0446	CrCbGaD
Flunisolide—SERPINA6—female reproductive system—breast cancer	0.000109	0.08	CbGeAlD
Flunisolide—SERPINA6—adrenal gland—breast cancer	0.000106	0.0781	CbGeAlD
Flunisolide—SERPINA6—bone marrow—breast cancer	0.000103	0.0756	CbGeAlD
Flunisolide—NR3C1—nipple—breast cancer	9.55e-05	0.0701	CbGeAlD
Flunisolide—Triamcinolone—BCHE—breast cancer	9.51e-05	0.0373	CrCbGaD
Flunisolide—SERPINA6—endocrine gland—breast cancer	9.23e-05	0.0677	CbGeAlD
Flunisolide—Dexamethasone—CYP17A1—breast cancer	8.93e-05	0.035	CrCbGaD
Flunisolide—Hydrocortisone—SHBG—breast cancer	8.3e-05	0.0326	CrCbGaD
Flunisolide—NR3C1—embryo—breast cancer	7.88e-05	0.0578	CbGeAlD
Flunisolide—Betamethasone—CYP19A1—breast cancer	7.81e-05	0.0306	CrCbGaD
Flunisolide—Dexamethasone—NOS2—breast cancer	7.28e-05	0.0285	CrCbGaD
Flunisolide—Budesonide—CYP3A4—breast cancer	6.79e-05	0.0266	CrCbGaD
Flunisolide—Fluticasone furoate—CYP3A4—breast cancer	6.66e-05	0.0261	CrCbGaD
Flunisolide—Dexamethasone—PGR—breast cancer	6.62e-05	0.026	CrCbGaD
Flunisolide—Ciclesonide—CYP2D6—breast cancer	6.45e-05	0.0253	CrCbGaD
Flunisolide—NR3C1—epithelium—breast cancer	6.43e-05	0.0472	CbGeAlD
Flunisolide—Dexamethasone—CYP1B1—breast cancer	6.19e-05	0.0243	CrCbGaD
Flunisolide—NR3C1—skin of body—breast cancer	6.12e-05	0.0449	CbGeAlD
Flunisolide—Alclometasone—CYP3A4—breast cancer	5.85e-05	0.0229	CrCbGaD
Flunisolide—NR3C1—endometrium—breast cancer	5.77e-05	0.0423	CbGeAlD
Flunisolide—Hydrocortisone—ABCG2—breast cancer	5.72e-05	0.0225	CrCbGaD
Flunisolide—Paramethasone—CYP3A4—breast cancer	5.63e-05	0.0221	CrCbGaD
Flunisolide—Fluticasone furoate—ABCB1—breast cancer	5.54e-05	0.0217	CrCbGaD
Flunisolide—Ciclesonide—CYP3A4—breast cancer	5.53e-05	0.0217	CrCbGaD
Flunisolide—Fluorometholone—CYP3A4—breast cancer	5.49e-05	0.0215	CrCbGaD
Flunisolide—NR3C1—uterus—breast cancer	5.31e-05	0.039	CbGeAlD
Flunisolide—Methylprednisolone—CYP3A4—breast cancer	5.31e-05	0.0208	CrCbGaD
Flunisolide—NR3C1—pituitary gland—breast cancer	5.22e-05	0.0383	CbGeAlD
Flunisolide—NR3C1—adipose tissue—breast cancer	5.2e-05	0.0381	CbGeAlD
Flunisolide—NR3C1—female reproductive system—breast cancer	4.78e-05	0.0351	CbGeAlD
Flunisolide—NR3C1—adrenal gland—breast cancer	4.66e-05	0.0342	CbGeAlD
Flunisolide—Dexamethasone—CYP19A1—breast cancer	4.54e-05	0.0178	CrCbGaD
Flunisolide—NR3C1—bone marrow—breast cancer	4.51e-05	0.0331	CbGeAlD
Flunisolide—Triamcinolone—CYP3A4—breast cancer	4.48e-05	0.0176	CrCbGaD
Flunisolide—Methylprednisolone—ABCB1—breast cancer	4.42e-05	0.0173	CrCbGaD
Flunisolide—Triamcinolone—PTGS2—breast cancer	4.38e-05	0.0172	CrCbGaD
Flunisolide—NR3C1—female gonad—breast cancer	4.35e-05	0.0319	CbGeAlD
Flunisolide—NR3C1—AP-1 transcription factor network—CCND1—breast cancer	4.33e-05	0.00122	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—JUN—breast cancer	4.32e-05	0.00122	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—CTNNB1—breast cancer	4.29e-05	0.00121	CbGpPWpGaD
Flunisolide—Dexamethasone—ABCG2—breast cancer	4.27e-05	0.0167	CrCbGaD
Flunisolide—NR3C1—Adipogenesis—LEP—breast cancer	4.26e-05	0.0012	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—MMP9—breast cancer	4.21e-05	0.00119	CbGpPWpGaD
Flunisolide—Pharyngitis—Methotrexate—breast cancer	4.19e-05	0.000352	CcSEcCtD
Flunisolide—Anxiety—Capecitabine—breast cancer	4.19e-05	0.000352	CcSEcCtD
Flunisolide—NR3C1—AP-1 transcription factor network—PTEN—breast cancer	4.18e-05	0.00118	CbGpPWpGaD
Flunisolide—Oedema—Docetaxel—breast cancer	4.17e-05	0.00035	CcSEcCtD
Flunisolide—Weight increased—Doxorubicin—breast cancer	4.16e-05	0.000349	CcSEcCtD
Flunisolide—Discomfort—Capecitabine—breast cancer	4.16e-05	0.000349	CcSEcCtD
Flunisolide—Epistaxis—Epirubicin—breast cancer	4.16e-05	0.000349	CcSEcCtD
Flunisolide—Pruritus—Gemcitabine—breast cancer	4.15e-05	0.000349	CcSEcCtD
Flunisolide—Nausea—Thiotepa—breast cancer	4.15e-05	0.000348	CcSEcCtD
Flunisolide—Infection—Docetaxel—breast cancer	4.14e-05	0.000348	CcSEcCtD
Flunisolide—Sinusitis—Epirubicin—breast cancer	4.13e-05	0.000347	CcSEcCtD
Flunisolide—Diarrhoea—Irinotecan—breast cancer	4.12e-05	0.000346	CcSEcCtD
Flunisolide—Diarrhoea—Mitoxantrone—breast cancer	4.12e-05	0.000346	CcSEcCtD
Flunisolide—Pneumonia—Doxorubicin—breast cancer	4.1e-05	0.000344	CcSEcCtD
Flunisolide—Shock—Docetaxel—breast cancer	4.1e-05	0.000344	CcSEcCtD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—breast cancer	4.1e-05	0.00116	CbGpPWpGaD
Flunisolide—Pruritus—Fluorouracil—breast cancer	4.08e-05	0.000343	CcSEcCtD
Flunisolide—Tachycardia—Docetaxel—breast cancer	4.07e-05	0.000341	CcSEcCtD
Flunisolide—NR3C1—Gene Expression—NR2F1—breast cancer	4.06e-05	0.00115	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—EEF1B2—breast cancer	4.06e-05	0.00115	CbGpPWpGaD
Flunisolide—Prednisone—CYP3A4—breast cancer	4.06e-05	0.0159	CrCbGaD
Flunisolide—Feeling abnormal—Paclitaxel—breast cancer	4.05e-05	0.00034	CcSEcCtD
Flunisolide—NR3C1—endocrine gland—breast cancer	4.04e-05	0.0297	CbGeAlD
Flunisolide—Oedema—Capecitabine—breast cancer	4.03e-05	0.000339	CcSEcCtD
Flunisolide—Gastrointestinal pain—Paclitaxel—breast cancer	4.02e-05	0.000338	CcSEcCtD
Flunisolide—Diarrhoea—Gemcitabine—breast cancer	4.02e-05	0.000337	CcSEcCtD
Flunisolide—Infection—Capecitabine—breast cancer	4.01e-05	0.000337	CcSEcCtD
Flunisolide—Fluticasone Propionate—CYP3A4—breast cancer	4e-05	0.0157	CrCbGaD
Flunisolide—Erythema multiforme—Methotrexate—breast cancer	4e-05	0.000336	CcSEcCtD
Flunisolide—Dizziness—Irinotecan—breast cancer	3.99e-05	0.000335	CcSEcCtD
Flunisolide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—breast cancer	3.98e-05	0.00112	CbGpPWpGaD
Flunisolide—Stomatitis—Doxorubicin—breast cancer	3.97e-05	0.000334	CcSEcCtD
Flunisolide—Shock—Capecitabine—breast cancer	3.97e-05	0.000333	CcSEcCtD
Flunisolide—Rhinitis—Epirubicin—breast cancer	3.97e-05	0.000333	CcSEcCtD
Flunisolide—Urinary tract infection—Doxorubicin—breast cancer	3.96e-05	0.000333	CcSEcCtD
Flunisolide—Conjunctivitis—Doxorubicin—breast cancer	3.96e-05	0.000333	CcSEcCtD
Flunisolide—Diarrhoea—Fluorouracil—breast cancer	3.95e-05	0.000332	CcSEcCtD
Flunisolide—Tachycardia—Capecitabine—breast cancer	3.94e-05	0.000331	CcSEcCtD
Flunisolide—Hypoaesthesia—Epirubicin—breast cancer	3.94e-05	0.000331	CcSEcCtD
Flunisolide—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—breast cancer	3.93e-05	0.00111	CbGpPWpGaD
Flunisolide—Pharyngitis—Epirubicin—breast cancer	3.93e-05	0.00033	CcSEcCtD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—IL2—breast cancer	3.92e-05	0.0011	CbGpPWpGaD
Flunisolide—Sweating—Doxorubicin—breast cancer	3.91e-05	0.000328	CcSEcCtD
Flunisolide—Urticaria—Paclitaxel—breast cancer	3.9e-05	0.000328	CcSEcCtD
Flunisolide—Hyperhidrosis—Capecitabine—breast cancer	3.9e-05	0.000327	CcSEcCtD
Flunisolide—Oedema peripheral—Epirubicin—breast cancer	3.9e-05	0.000327	CcSEcCtD
Flunisolide—Abdominal pain—Paclitaxel—breast cancer	3.89e-05	0.000326	CcSEcCtD
Flunisolide—Body temperature increased—Paclitaxel—breast cancer	3.89e-05	0.000326	CcSEcCtD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—breast cancer	3.85e-05	0.00108	CbGpPWpGaD
Flunisolide—Epistaxis—Doxorubicin—breast cancer	3.85e-05	0.000323	CcSEcCtD
Flunisolide—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—breast cancer	3.84e-05	0.00108	CbGpPWpGaD
Flunisolide—Vomiting—Irinotecan—breast cancer	3.83e-05	0.000322	CcSEcCtD
Flunisolide—Vomiting—Mitoxantrone—breast cancer	3.83e-05	0.000322	CcSEcCtD
Flunisolide—Sinusitis—Doxorubicin—breast cancer	3.82e-05	0.000321	CcSEcCtD
Flunisolide—Dizziness—Fluorouracil—breast cancer	3.82e-05	0.000321	CcSEcCtD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—JUN—breast cancer	3.81e-05	0.00107	CbGpPWpGaD
Flunisolide—CYP3A4—Cytochrome P450 - arranged by substrate type—NCOA1—breast cancer	3.8e-05	0.00107	CbGpPWpGaD
Flunisolide—Rash—Irinotecan—breast cancer	3.8e-05	0.000319	CcSEcCtD
Flunisolide—Rash—Mitoxantrone—breast cancer	3.8e-05	0.000319	CcSEcCtD
Flunisolide—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—breast cancer	3.8e-05	0.00107	CbGpPWpGaD
Flunisolide—Dermatitis—Irinotecan—breast cancer	3.8e-05	0.000319	CcSEcCtD
Flunisolide—Dermatitis—Mitoxantrone—breast cancer	3.8e-05	0.000319	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Docetaxel—breast cancer	3.8e-05	0.000319	CcSEcCtD
Flunisolide—Chills—Methotrexate—breast cancer	3.79e-05	0.000318	CcSEcCtD
Flunisolide—NR3C1—Gene Expression—NR2F6—breast cancer	3.78e-05	0.00107	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—HNF4G—breast cancer	3.78e-05	0.00107	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—HIF1A—breast cancer	3.78e-05	0.00106	CbGpPWpGaD
Flunisolide—Headache—Mitoxantrone—breast cancer	3.78e-05	0.000317	CcSEcCtD
Flunisolide—Headache—Irinotecan—breast cancer	3.78e-05	0.000317	CcSEcCtD
Flunisolide—Insomnia—Docetaxel—breast cancer	3.77e-05	0.000316	CcSEcCtD
Flunisolide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—breast cancer	3.75e-05	0.00106	CbGpPWpGaD
Flunisolide—Prednisolone—CYP3A4—breast cancer	3.74e-05	0.0147	CrCbGaD
Flunisolide—Erythema multiforme—Epirubicin—breast cancer	3.74e-05	0.000314	CcSEcCtD
Flunisolide—CYP3A4—Tryptophan metabolism—CYP1A1—breast cancer	3.73e-05	0.00105	CbGpPWpGaD
Flunisolide—Vomiting—Gemcitabine—breast cancer	3.73e-05	0.000313	CcSEcCtD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—breast cancer	3.73e-05	0.00105	CbGpPWpGaD
Flunisolide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—breast cancer	3.72e-05	0.00105	CbGpPWpGaD
Flunisolide—Dyspnoea—Docetaxel—breast cancer	3.71e-05	0.000312	CcSEcCtD
Flunisolide—Rash—Gemcitabine—breast cancer	3.7e-05	0.000311	CcSEcCtD
Flunisolide—Dermatitis—Gemcitabine—breast cancer	3.7e-05	0.000311	CcSEcCtD
Flunisolide—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—breast cancer	3.7e-05	0.00104	CbGpPWpGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—breast cancer	3.69e-05	0.00104	CbGpPWpGaD
Flunisolide—Malnutrition—Methotrexate—breast cancer	3.68e-05	0.000309	CcSEcCtD
Flunisolide—Headache—Gemcitabine—breast cancer	3.68e-05	0.000309	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Capecitabine—breast cancer	3.68e-05	0.000309	CcSEcCtD
Flunisolide—Vomiting—Fluorouracil—breast cancer	3.67e-05	0.000308	CcSEcCtD
Flunisolide—Rhinitis—Doxorubicin—breast cancer	3.67e-05	0.000308	CcSEcCtD
Flunisolide—Dyspepsia—Docetaxel—breast cancer	3.67e-05	0.000308	CcSEcCtD
Flunisolide—Betamethasone—CYP3A4—breast cancer	3.67e-05	0.0144	CrCbGaD
Flunisolide—CYP3A4—Biological oxidations—ALDH1A1—breast cancer	3.66e-05	0.00103	CbGpPWpGaD
Flunisolide—CYP3A4—Phase 1 - Functionalization of compounds—NCOA2—breast cancer	3.66e-05	0.00103	CbGpPWpGaD
Flunisolide—Insomnia—Capecitabine—breast cancer	3.65e-05	0.000306	CcSEcCtD
Flunisolide—Hypoaesthesia—Doxorubicin—breast cancer	3.64e-05	0.000306	CcSEcCtD
Flunisolide—Rash—Fluorouracil—breast cancer	3.64e-05	0.000306	CcSEcCtD
Flunisolide—Dermatitis—Fluorouracil—breast cancer	3.64e-05	0.000305	CcSEcCtD
Flunisolide—Pharyngitis—Doxorubicin—breast cancer	3.63e-05	0.000305	CcSEcCtD
Flunisolide—Decreased appetite—Docetaxel—breast cancer	3.62e-05	0.000304	CcSEcCtD
Flunisolide—Hypersensitivity—Paclitaxel—breast cancer	3.62e-05	0.000304	CcSEcCtD
Flunisolide—Headache—Fluorouracil—breast cancer	3.62e-05	0.000304	CcSEcCtD
Flunisolide—CYP3A4—female reproductive system—breast cancer	3.61e-05	0.0265	CbGeAlD
Flunisolide—Oedema peripheral—Doxorubicin—breast cancer	3.61e-05	0.000303	CcSEcCtD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—breast cancer	3.6e-05	0.00102	CbGpPWpGaD
Flunisolide—Dysgeusia—Methotrexate—breast cancer	3.6e-05	0.000303	CcSEcCtD
Flunisolide—Dyspnoea—Capecitabine—breast cancer	3.6e-05	0.000302	CcSEcCtD
Flunisolide—Fatigue—Docetaxel—breast cancer	3.59e-05	0.000302	CcSEcCtD
Flunisolide—Betamethasone—PTGS2—breast cancer	3.59e-05	0.0141	CrCbGaD
Flunisolide—Nausea—Mitoxantrone—breast cancer	3.58e-05	0.000301	CcSEcCtD
Flunisolide—Nausea—Irinotecan—breast cancer	3.58e-05	0.000301	CcSEcCtD
Flunisolide—Pain—Docetaxel—breast cancer	3.56e-05	0.000299	CcSEcCtD
Flunisolide—Constipation—Docetaxel—breast cancer	3.56e-05	0.000299	CcSEcCtD
Flunisolide—Back pain—Methotrexate—breast cancer	3.56e-05	0.000299	CcSEcCtD
Flunisolide—NR3C1—Adipogenesis—RB1—breast cancer	3.56e-05	0.001	CbGpPWpGaD
Flunisolide—Dyspepsia—Capecitabine—breast cancer	3.55e-05	0.000298	CcSEcCtD
Flunisolide—Chills—Epirubicin—breast cancer	3.55e-05	0.000298	CcSEcCtD
Flunisolide—NR3C1—Endoderm Differentiation—TGFB1—breast cancer	3.55e-05	0.001	CbGpPWpGaD
Flunisolide—Prednisone—ALB—breast cancer	3.54e-05	0.0139	CrCbGaD
Flunisolide—Asthenia—Paclitaxel—breast cancer	3.53e-05	0.000296	CcSEcCtD
Flunisolide—NR3C1—Adipogenesis—IGF1—breast cancer	3.52e-05	0.000994	CbGpPWpGaD
Flunisolide—Decreased appetite—Capecitabine—breast cancer	3.51e-05	0.000294	CcSEcCtD
Flunisolide—NR3C1—Generic Transcription Pathway—RARB—breast cancer	3.5e-05	0.000988	CbGpPWpGaD
Flunisolide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—breast cancer	3.49e-05	0.000985	CbGpPWpGaD
Flunisolide—Nausea—Gemcitabine—breast cancer	3.49e-05	0.000293	CcSEcCtD
Flunisolide—Fatigue—Capecitabine—breast cancer	3.48e-05	0.000292	CcSEcCtD
Flunisolide—Pruritus—Paclitaxel—breast cancer	3.48e-05	0.000292	CcSEcCtD
Flunisolide—NR3C1—AP-1 transcription factor network—MYC—breast cancer	3.48e-05	0.00098	CbGpPWpGaD
Flunisolide—Vision blurred—Methotrexate—breast cancer	3.47e-05	0.000291	CcSEcCtD
Flunisolide—NR3C1—AP-1 transcription factor network—TGFB1—breast cancer	3.47e-05	0.000978	CbGpPWpGaD
Flunisolide—Erythema multiforme—Doxorubicin—breast cancer	3.46e-05	0.000291	CcSEcCtD
Flunisolide—Constipation—Capecitabine—breast cancer	3.45e-05	0.00029	CcSEcCtD
Flunisolide—Pain—Capecitabine—breast cancer	3.45e-05	0.00029	CcSEcCtD
Flunisolide—Malnutrition—Epirubicin—breast cancer	3.44e-05	0.000289	CcSEcCtD
Flunisolide—Feeling abnormal—Docetaxel—breast cancer	3.43e-05	0.000288	CcSEcCtD
Flunisolide—Nausea—Fluorouracil—breast cancer	3.43e-05	0.000288	CcSEcCtD
Flunisolide—Ill-defined disorder—Methotrexate—breast cancer	3.41e-05	0.000287	CcSEcCtD
Flunisolide—Gastrointestinal pain—Docetaxel—breast cancer	3.41e-05	0.000286	CcSEcCtD
Flunisolide—Prednisone—ABCB1—breast cancer	3.38e-05	0.0133	CrCbGaD
Flunisolide—Dysgeusia—Epirubicin—breast cancer	3.37e-05	0.000283	CcSEcCtD
Flunisolide—NR3C1—Gene Expression—HNRNPL—breast cancer	3.37e-05	0.00095	CbGpPWpGaD
Flunisolide—Diarrhoea—Paclitaxel—breast cancer	3.36e-05	0.000282	CcSEcCtD
Flunisolide—NR3C1—Generic Transcription Pathway—MED12—breast cancer	3.36e-05	0.000948	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—SERPINE1—breast cancer	3.35e-05	0.000944	CbGpPWpGaD
Flunisolide—Dexamethasone—CYP1A1—breast cancer	3.34e-05	0.0131	CrCbGaD
Flunisolide—Back pain—Epirubicin—breast cancer	3.33e-05	0.00028	CcSEcCtD
Flunisolide—Feeling abnormal—Capecitabine—breast cancer	3.32e-05	0.000279	CcSEcCtD
Flunisolide—Malaise—Methotrexate—breast cancer	3.32e-05	0.000279	CcSEcCtD
Flunisolide—Vertigo—Methotrexate—breast cancer	3.31e-05	0.000278	CcSEcCtD
Flunisolide—Gastrointestinal pain—Capecitabine—breast cancer	3.3e-05	0.000277	CcSEcCtD
Flunisolide—Abdominal pain—Docetaxel—breast cancer	3.29e-05	0.000277	CcSEcCtD
Flunisolide—Body temperature increased—Docetaxel—breast cancer	3.29e-05	0.000277	CcSEcCtD
Flunisolide—Chills—Doxorubicin—breast cancer	3.28e-05	0.000276	CcSEcCtD
Flunisolide—CYP3A4—Biological oxidations—GSTA3—breast cancer	3.27e-05	0.000921	CbGpPWpGaD
Flunisolide—Dizziness—Paclitaxel—breast cancer	3.25e-05	0.000273	CcSEcCtD
Flunisolide—Vision blurred—Epirubicin—breast cancer	3.24e-05	0.000273	CcSEcCtD
Flunisolide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—breast cancer	3.23e-05	0.000911	CbGpPWpGaD
Flunisolide—CYP3A4—Metapathway biotransformation—GSTA3—breast cancer	3.22e-05	0.000908	CbGpPWpGaD
Flunisolide—Cough—Methotrexate—breast cancer	3.21e-05	0.00027	CcSEcCtD
Flunisolide—Urticaria—Capecitabine—breast cancer	3.2e-05	0.000269	CcSEcCtD
Flunisolide—Ill-defined disorder—Epirubicin—breast cancer	3.19e-05	0.000268	CcSEcCtD
Flunisolide—Body temperature increased—Capecitabine—breast cancer	3.19e-05	0.000268	CcSEcCtD
Flunisolide—Abdominal pain—Capecitabine—breast cancer	3.19e-05	0.000268	CcSEcCtD
Flunisolide—Malnutrition—Doxorubicin—breast cancer	3.19e-05	0.000268	CcSEcCtD
Flunisolide—Agitation—Epirubicin—breast cancer	3.16e-05	0.000266	CcSEcCtD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—breast cancer	3.15e-05	0.000888	CbGpPWpGaD
Flunisolide—Chest pain—Methotrexate—breast cancer	3.13e-05	0.000263	CcSEcCtD
Flunisolide—Myalgia—Methotrexate—breast cancer	3.13e-05	0.000263	CcSEcCtD
Flunisolide—Vomiting—Paclitaxel—breast cancer	3.13e-05	0.000262	CcSEcCtD
Flunisolide—Dysgeusia—Doxorubicin—breast cancer	3.12e-05	0.000262	CcSEcCtD
Flunisolide—Prednisolone—ABCB1—breast cancer	3.12e-05	0.0122	CrCbGaD
Flunisolide—Malaise—Epirubicin—breast cancer	3.11e-05	0.000261	CcSEcCtD
Flunisolide—Rash—Paclitaxel—breast cancer	3.1e-05	0.00026	CcSEcCtD
Flunisolide—Dermatitis—Paclitaxel—breast cancer	3.1e-05	0.00026	CcSEcCtD
Flunisolide—Discomfort—Methotrexate—breast cancer	3.09e-05	0.00026	CcSEcCtD
Flunisolide—Vertigo—Epirubicin—breast cancer	3.09e-05	0.00026	CcSEcCtD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—breast cancer	3.09e-05	0.000872	CbGpPWpGaD
Flunisolide—Syncope—Epirubicin—breast cancer	3.09e-05	0.000259	CcSEcCtD
Flunisolide—Back pain—Doxorubicin—breast cancer	3.08e-05	0.000259	CcSEcCtD
Flunisolide—CYP3A4—Phase 1 - Functionalization of compounds—NCOA1—breast cancer	3.08e-05	0.000869	CbGpPWpGaD
Flunisolide—Headache—Paclitaxel—breast cancer	3.08e-05	0.000259	CcSEcCtD
Flunisolide—Hypersensitivity—Docetaxel—breast cancer	3.07e-05	0.000258	CcSEcCtD
Flunisolide—CYP3A4—endocrine gland—breast cancer	3.06e-05	0.0224	CbGeAlD
Flunisolide—Betamethasone—ABCB1—breast cancer	3.05e-05	0.012	CrCbGaD
Flunisolide—NR3C1—Generic Transcription Pathway—NOTCH4—breast cancer	3.04e-05	0.000858	CbGpPWpGaD
Flunisolide—Palpitations—Epirubicin—breast cancer	3.04e-05	0.000256	CcSEcCtD
Flunisolide—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—breast cancer	3.04e-05	0.000856	CbGpPWpGaD
Flunisolide—Loss of consciousness—Epirubicin—breast cancer	3.03e-05	0.000254	CcSEcCtD
Flunisolide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—breast cancer	3.02e-05	0.000851	CbGpPWpGaD
Flunisolide—Cough—Epirubicin—breast cancer	3e-05	0.000252	CcSEcCtD
Flunisolide—Vision blurred—Doxorubicin—breast cancer	3e-05	0.000252	CcSEcCtD
Flunisolide—Asthenia—Docetaxel—breast cancer	2.99e-05	0.000251	CcSEcCtD
Flunisolide—CYP3A4—Biological oxidations—GSTA4—breast cancer	2.99e-05	0.000842	CbGpPWpGaD
Flunisolide—Infection—Methotrexate—breast cancer	2.98e-05	0.000251	CcSEcCtD
Flunisolide—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—breast cancer	2.98e-05	0.00084	CbGpPWpGaD
Flunisolide—Hypertension—Epirubicin—breast cancer	2.97e-05	0.00025	CcSEcCtD
Flunisolide—Hypersensitivity—Capecitabine—breast cancer	2.97e-05	0.00025	CcSEcCtD
Flunisolide—Ill-defined disorder—Doxorubicin—breast cancer	2.96e-05	0.000248	CcSEcCtD
Flunisolide—Pruritus—Docetaxel—breast cancer	2.95e-05	0.000248	CcSEcCtD
Flunisolide—CYP3A4—Metapathway biotransformation—GSTA4—breast cancer	2.95e-05	0.000831	CbGpPWpGaD
Flunisolide—Chest pain—Epirubicin—breast cancer	2.93e-05	0.000246	CcSEcCtD
Flunisolide—Myalgia—Epirubicin—breast cancer	2.93e-05	0.000246	CcSEcCtD
Flunisolide—Agitation—Doxorubicin—breast cancer	2.93e-05	0.000246	CcSEcCtD
Flunisolide—Anxiety—Epirubicin—breast cancer	2.92e-05	0.000245	CcSEcCtD
Flunisolide—Nausea—Paclitaxel—breast cancer	2.92e-05	0.000245	CcSEcCtD
Flunisolide—CYP3A4—Biological oxidations—GSTA2—breast cancer	2.91e-05	0.000821	CbGpPWpGaD
Flunisolide—Hyperhidrosis—Methotrexate—breast cancer	2.9e-05	0.000244	CcSEcCtD
Flunisolide—Discomfort—Epirubicin—breast cancer	2.9e-05	0.000243	CcSEcCtD
Flunisolide—Asthenia—Capecitabine—breast cancer	2.89e-05	0.000243	CcSEcCtD
Flunisolide—CYP3A4—Biological oxidations—SULT1A1—breast cancer	2.87e-05	0.000811	CbGpPWpGaD
Flunisolide—Malaise—Doxorubicin—breast cancer	2.87e-05	0.000241	CcSEcCtD
Flunisolide—CYP3A4—Metapathway biotransformation—GPX2—breast cancer	2.87e-05	0.000809	CbGpPWpGaD
Flunisolide—Vertigo—Doxorubicin—breast cancer	2.86e-05	0.00024	CcSEcCtD
Flunisolide—Hydrocortisone—CYP3A4—breast cancer	2.86e-05	0.0112	CrCbGaD
Flunisolide—Syncope—Doxorubicin—breast cancer	2.86e-05	0.00024	CcSEcCtD
Flunisolide—Pruritus—Capecitabine—breast cancer	2.85e-05	0.00024	CcSEcCtD
Flunisolide—NR3C1—AP-1 transcription factor network—TP53—breast cancer	2.85e-05	0.000805	CbGpPWpGaD
Flunisolide—Diarrhoea—Docetaxel—breast cancer	2.85e-05	0.000239	CcSEcCtD
Flunisolide—CYP3A4—Metapathway biotransformation—GPX4—breast cancer	2.84e-05	0.0008	CbGpPWpGaD
Flunisolide—CYP3A4—Metapathway biotransformation—SULT1A1—breast cancer	2.84e-05	0.0008	CbGpPWpGaD
Flunisolide—Palpitations—Doxorubicin—breast cancer	2.82e-05	0.000236	CcSEcCtD
Flunisolide—Oedema—Epirubicin—breast cancer	2.81e-05	0.000236	CcSEcCtD
Flunisolide—CYP3A4—Biological oxidations—GSTA1—breast cancer	2.81e-05	0.000792	CbGpPWpGaD
Flunisolide—Loss of consciousness—Doxorubicin—breast cancer	2.8e-05	0.000235	CcSEcCtD
Flunisolide—NR3C1—lymph node—breast cancer	2.79e-05	0.0205	CbGeAlD
Flunisolide—Infection—Epirubicin—breast cancer	2.79e-05	0.000234	CcSEcCtD
Flunisolide—NR3C1—Generic Transcription Pathway—PGR—breast cancer	2.78e-05	0.000785	CbGpPWpGaD
Flunisolide—Cough—Doxorubicin—breast cancer	2.78e-05	0.000233	CcSEcCtD
Flunisolide—CYP3A4—Biological oxidations—NAT2—breast cancer	2.78e-05	0.000783	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—EIF2S2—breast cancer	2.77e-05	0.000782	CbGpPWpGaD
Flunisolide—Shock—Epirubicin—breast cancer	2.76e-05	0.000232	CcSEcCtD
Flunisolide—Diarrhoea—Capecitabine—breast cancer	2.76e-05	0.000232	CcSEcCtD
Flunisolide—Dizziness—Docetaxel—breast cancer	2.76e-05	0.000231	CcSEcCtD
Flunisolide—Hypertension—Doxorubicin—breast cancer	2.75e-05	0.000231	CcSEcCtD
Flunisolide—Tachycardia—Epirubicin—breast cancer	2.74e-05	0.00023	CcSEcCtD
Flunisolide—CYP3A4—Metapathway biotransformation—NAT2—breast cancer	2.74e-05	0.000772	CbGpPWpGaD
Flunisolide—Musculoskeletal discomfort—Methotrexate—breast cancer	2.74e-05	0.00023	CcSEcCtD
Flunisolide—Hyperhidrosis—Epirubicin—breast cancer	2.72e-05	0.000228	CcSEcCtD
Flunisolide—Insomnia—Methotrexate—breast cancer	2.72e-05	0.000228	CcSEcCtD
Flunisolide—Chest pain—Doxorubicin—breast cancer	2.71e-05	0.000228	CcSEcCtD
Flunisolide—Myalgia—Doxorubicin—breast cancer	2.71e-05	0.000228	CcSEcCtD
Flunisolide—Anxiety—Doxorubicin—breast cancer	2.7e-05	0.000227	CcSEcCtD
Flunisolide—NR3C1—Gene Expression—ESRRA—breast cancer	2.69e-05	0.000759	CbGpPWpGaD
Flunisolide—NR3C1—Generic Transcription Pathway—NCOA2—breast cancer	2.68e-05	0.000756	CbGpPWpGaD
Flunisolide—Discomfort—Doxorubicin—breast cancer	2.68e-05	0.000225	CcSEcCtD
Flunisolide—Dyspnoea—Methotrexate—breast cancer	2.68e-05	0.000225	CcSEcCtD
Flunisolide—Dizziness—Capecitabine—breast cancer	2.67e-05	0.000224	CcSEcCtD
Flunisolide—Vomiting—Docetaxel—breast cancer	2.65e-05	0.000222	CcSEcCtD
Flunisolide—Dyspepsia—Methotrexate—breast cancer	2.64e-05	0.000222	CcSEcCtD
Flunisolide—Rash—Docetaxel—breast cancer	2.63e-05	0.000221	CcSEcCtD
Flunisolide—Dermatitis—Docetaxel—breast cancer	2.62e-05	0.00022	CcSEcCtD
Flunisolide—NR3C1—Adipogenesis—CTNNB1—breast cancer	2.61e-05	0.000737	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—IL6—breast cancer	2.61e-05	0.000737	CbGpPWpGaD
Flunisolide—Decreased appetite—Methotrexate—breast cancer	2.61e-05	0.000219	CcSEcCtD
Flunisolide—Headache—Docetaxel—breast cancer	2.61e-05	0.000219	CcSEcCtD
Flunisolide—Oedema—Doxorubicin—breast cancer	2.6e-05	0.000218	CcSEcCtD
Flunisolide—Fatigue—Methotrexate—breast cancer	2.59e-05	0.000217	CcSEcCtD
Flunisolide—NR3C1—Generic Transcription Pathway—NOTCH3—breast cancer	2.59e-05	0.00073	CbGpPWpGaD
Flunisolide—NR3C1—Generic Transcription Pathway—PARP1—breast cancer	2.59e-05	0.00073	CbGpPWpGaD
Flunisolide—Infection—Doxorubicin—breast cancer	2.58e-05	0.000217	CcSEcCtD
Flunisolide—Pain—Methotrexate—breast cancer	2.57e-05	0.000216	CcSEcCtD
Flunisolide—Vomiting—Capecitabine—breast cancer	2.56e-05	0.000215	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Epirubicin—breast cancer	2.56e-05	0.000215	CcSEcCtD
Flunisolide—Shock—Doxorubicin—breast cancer	2.56e-05	0.000215	CcSEcCtD
Flunisolide—NR3C1—Adipogenesis—CDKN1A—breast cancer	2.55e-05	0.00072	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—YBX1—breast cancer	2.55e-05	0.00072	CbGpPWpGaD
Flunisolide—Rash—Capecitabine—breast cancer	2.54e-05	0.000214	CcSEcCtD
Flunisolide—Insomnia—Epirubicin—breast cancer	2.54e-05	0.000213	CcSEcCtD
Flunisolide—Dermatitis—Capecitabine—breast cancer	2.54e-05	0.000213	CcSEcCtD
Flunisolide—Tachycardia—Doxorubicin—breast cancer	2.54e-05	0.000213	CcSEcCtD
Flunisolide—Headache—Capecitabine—breast cancer	2.53e-05	0.000212	CcSEcCtD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—TP53—breast cancer	2.51e-05	0.000709	CbGpPWpGaD
Flunisolide—Hyperhidrosis—Doxorubicin—breast cancer	2.51e-05	0.000211	CcSEcCtD
Flunisolide—Dyspnoea—Epirubicin—breast cancer	2.51e-05	0.00021	CcSEcCtD
Flunisolide—Dexamethasone—CYP2D6—breast cancer	2.49e-05	0.00975	CrCbGaD
Flunisolide—Nausea—Docetaxel—breast cancer	2.47e-05	0.000208	CcSEcCtD
Flunisolide—Feeling abnormal—Methotrexate—breast cancer	2.47e-05	0.000208	CcSEcCtD
Flunisolide—Dyspepsia—Epirubicin—breast cancer	2.47e-05	0.000208	CcSEcCtD
Flunisolide—Gastrointestinal pain—Methotrexate—breast cancer	2.46e-05	0.000206	CcSEcCtD
Flunisolide—NR3C1—Generic Transcription Pathway—ESR2—breast cancer	2.45e-05	0.000691	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—CXCL8—breast cancer	2.45e-05	0.000691	CbGpPWpGaD
Flunisolide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—breast cancer	2.45e-05	0.00069	CbGpPWpGaD
Flunisolide—Decreased appetite—Epirubicin—breast cancer	2.44e-05	0.000205	CcSEcCtD
Flunisolide—NR3C1—Gene Expression—EEF2—breast cancer	2.43e-05	0.000686	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—THRB—breast cancer	2.43e-05	0.000686	CbGpPWpGaD
Flunisolide—Fatigue—Epirubicin—breast cancer	2.42e-05	0.000203	CcSEcCtD
Flunisolide—Constipation—Epirubicin—breast cancer	2.4e-05	0.000202	CcSEcCtD
Flunisolide—Pain—Epirubicin—breast cancer	2.4e-05	0.000202	CcSEcCtD
Flunisolide—Nausea—Capecitabine—breast cancer	2.4e-05	0.000201	CcSEcCtD
Flunisolide—Urticaria—Methotrexate—breast cancer	2.39e-05	0.0002	CcSEcCtD
Flunisolide—Hydrocortisone—ABCB1—breast cancer	2.38e-05	0.00934	CrCbGaD
Flunisolide—Abdominal pain—Methotrexate—breast cancer	2.37e-05	0.000199	CcSEcCtD
Flunisolide—Body temperature increased—Methotrexate—breast cancer	2.37e-05	0.000199	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Doxorubicin—breast cancer	2.37e-05	0.000199	CcSEcCtD
Flunisolide—Insomnia—Doxorubicin—breast cancer	2.35e-05	0.000197	CcSEcCtD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—IL1B—breast cancer	2.35e-05	0.000663	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—CASP3—breast cancer	2.34e-05	0.000661	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—TET2—breast cancer	2.33e-05	0.000658	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—RXRB—breast cancer	2.33e-05	0.000658	CbGpPWpGaD
Flunisolide—NR3C1—Generic Transcription Pathway—NOTCH2—breast cancer	2.32e-05	0.000655	CbGpPWpGaD
Flunisolide—Dyspnoea—Doxorubicin—breast cancer	2.32e-05	0.000195	CcSEcCtD
Flunisolide—Feeling abnormal—Epirubicin—breast cancer	2.32e-05	0.000194	CcSEcCtD
Flunisolide—CYP3A4—Tryptophan metabolism—MDM2—breast cancer	2.3e-05	0.00065	CbGpPWpGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—IL6—breast cancer	2.3e-05	0.000649	CbGpPWpGaD
Flunisolide—Gastrointestinal pain—Epirubicin—breast cancer	2.3e-05	0.000193	CcSEcCtD
Flunisolide—NR3C1—Gene Expression—RPL31—breast cancer	2.29e-05	0.000645	CbGpPWpGaD
Flunisolide—Dyspepsia—Doxorubicin—breast cancer	2.29e-05	0.000192	CcSEcCtD
Flunisolide—NR3C1—Adipogenesis—STAT3—breast cancer	2.28e-05	0.000643	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—JUN—breast cancer	2.28e-05	0.000642	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—MTR—breast cancer	2.26e-05	0.000638	CbGpPWpGaD
Flunisolide—Decreased appetite—Doxorubicin—breast cancer	2.26e-05	0.00019	CcSEcCtD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—CTNNB1—breast cancer	2.26e-05	0.000637	CbGpPWpGaD
Flunisolide—NR3C1—Generic Transcription Pathway—NCOA1—breast cancer	2.26e-05	0.000637	CbGpPWpGaD
Flunisolide—Fatigue—Doxorubicin—breast cancer	2.24e-05	0.000188	CcSEcCtD
Flunisolide—Urticaria—Epirubicin—breast cancer	2.23e-05	0.000187	CcSEcCtD
Flunisolide—Constipation—Doxorubicin—breast cancer	2.22e-05	0.000187	CcSEcCtD
Flunisolide—Pain—Doxorubicin—breast cancer	2.22e-05	0.000187	CcSEcCtD
Flunisolide—Body temperature increased—Epirubicin—breast cancer	2.22e-05	0.000187	CcSEcCtD
Flunisolide—Abdominal pain—Epirubicin—breast cancer	2.22e-05	0.000187	CcSEcCtD
Flunisolide—CYP3A4—Biological oxidations—HPGDS—breast cancer	2.22e-05	0.000626	CbGpPWpGaD
Flunisolide—Hypersensitivity—Methotrexate—breast cancer	2.21e-05	0.000186	CcSEcCtD
Flunisolide—NR3C1—Generic Transcription Pathway—AR—breast cancer	2.17e-05	0.000611	CbGpPWpGaD
Flunisolide—Asthenia—Methotrexate—breast cancer	2.15e-05	0.000181	CcSEcCtD
Flunisolide—CYP3A4—Biological oxidations—GSTT1—breast cancer	2.15e-05	0.000607	CbGpPWpGaD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—breast cancer	2.14e-05	0.000605	CbGpPWpGaD
Flunisolide—Feeling abnormal—Doxorubicin—breast cancer	2.14e-05	0.00018	CcSEcCtD
Flunisolide—NR3C1—Gene Expression—RPS4X—breast cancer	2.13e-05	0.000602	CbGpPWpGaD
Flunisolide—Dexamethasone—CYP3A4—breast cancer	2.13e-05	0.00836	CrCbGaD
Flunisolide—Gastrointestinal pain—Doxorubicin—breast cancer	2.13e-05	0.000179	CcSEcCtD
Flunisolide—Pruritus—Methotrexate—breast cancer	2.12e-05	0.000178	CcSEcCtD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—breast cancer	2.12e-05	0.000599	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—TGFB1—breast cancer	2.11e-05	0.000596	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—EIF3A—breast cancer	2.1e-05	0.000593	CbGpPWpGaD
Flunisolide—Dexamethasone—PTGS2—breast cancer	2.09e-05	0.00819	CrCbGaD
Flunisolide—Hypersensitivity—Epirubicin—breast cancer	2.07e-05	0.000174	CcSEcCtD
Flunisolide—NR3C1—Gene Expression—DNMT3A—breast cancer	2.07e-05	0.000584	CbGpPWpGaD
Flunisolide—Urticaria—Doxorubicin—breast cancer	2.07e-05	0.000173	CcSEcCtD
Flunisolide—Body temperature increased—Doxorubicin—breast cancer	2.06e-05	0.000173	CcSEcCtD
Flunisolide—Abdominal pain—Doxorubicin—breast cancer	2.06e-05	0.000173	CcSEcCtD
Flunisolide—Diarrhoea—Methotrexate—breast cancer	2.05e-05	0.000173	CcSEcCtD
Flunisolide—NR3C1—Gene Expression—ELL—breast cancer	2.04e-05	0.000575	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—CYP17A1—breast cancer	2.04e-05	0.000575	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—PTGS1—breast cancer	2.02e-05	0.000569	CbGpPWpGaD
Flunisolide—Asthenia—Epirubicin—breast cancer	2.02e-05	0.000169	CcSEcCtD
Flunisolide—CYP3A4—Metapathway biotransformation—CYP17A1—breast cancer	2.01e-05	0.000567	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—VEGFA—breast cancer	1.99e-05	0.000561	CbGpPWpGaD
Flunisolide—Pruritus—Epirubicin—breast cancer	1.99e-05	0.000167	CcSEcCtD
Flunisolide—Dizziness—Methotrexate—breast cancer	1.99e-05	0.000167	CcSEcCtD
Flunisolide—CYP3A4—Biological oxidations—CYP2D6—breast cancer	1.98e-05	0.000558	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—TNF—breast cancer	1.97e-05	0.000556	CbGpPWpGaD
Flunisolide—CYP3A4—Metapathway biotransformation—CYP2D6—breast cancer	1.95e-05	0.00055	CbGpPWpGaD
Flunisolide—NR3C1—Generic Transcription Pathway—SMAD4—breast cancer	1.95e-05	0.00055	CbGpPWpGaD
Flunisolide—NR3C1—Generic Transcription Pathway—VDR—breast cancer	1.95e-05	0.000549	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—NCOA2—breast cancer	1.94e-05	0.000548	CbGpPWpGaD
Flunisolide—Diarrhoea—Epirubicin—breast cancer	1.92e-05	0.000161	CcSEcCtD
Flunisolide—Hypersensitivity—Doxorubicin—breast cancer	1.92e-05	0.000161	CcSEcCtD
Flunisolide—Vomiting—Methotrexate—breast cancer	1.91e-05	0.00016	CcSEcCtD
Flunisolide—Rash—Methotrexate—breast cancer	1.89e-05	0.000159	CcSEcCtD
Flunisolide—NR3C1—Generic Transcription Pathway—NCOR1—breast cancer	1.89e-05	0.000534	CbGpPWpGaD
Flunisolide—Dermatitis—Methotrexate—breast cancer	1.89e-05	0.000159	CcSEcCtD
Flunisolide—NR3C1—Gene Expression—PABPC1—breast cancer	1.89e-05	0.000532	CbGpPWpGaD
Flunisolide—Headache—Methotrexate—breast cancer	1.88e-05	0.000158	CcSEcCtD
Flunisolide—Asthenia—Doxorubicin—breast cancer	1.87e-05	0.000157	CcSEcCtD
Flunisolide—Dizziness—Epirubicin—breast cancer	1.86e-05	0.000156	CcSEcCtD
Flunisolide—Pruritus—Doxorubicin—breast cancer	1.84e-05	0.000154	CcSEcCtD
Flunisolide—Vomiting—Epirubicin—breast cancer	1.79e-05	0.00015	CcSEcCtD
Flunisolide—Nausea—Methotrexate—breast cancer	1.78e-05	0.00015	CcSEcCtD
Flunisolide—Diarrhoea—Doxorubicin—breast cancer	1.78e-05	0.000149	CcSEcCtD
Flunisolide—Dexamethasone—ABCB1—breast cancer	1.78e-05	0.00696	CrCbGaD
Flunisolide—Rash—Epirubicin—breast cancer	1.77e-05	0.000149	CcSEcCtD
Flunisolide—Dermatitis—Epirubicin—breast cancer	1.77e-05	0.000149	CcSEcCtD
Flunisolide—NR3C1—Gene Expression—DNMT3B—breast cancer	1.77e-05	0.000499	CbGpPWpGaD
Flunisolide—Headache—Epirubicin—breast cancer	1.76e-05	0.000148	CcSEcCtD
Flunisolide—NR3C1—Gene Expression—RPL23A—breast cancer	1.73e-05	0.000489	CbGpPWpGaD
Flunisolide—Dizziness—Doxorubicin—breast cancer	1.72e-05	0.000144	CcSEcCtD
Flunisolide—CYP3A4—Biological oxidations—CYP1B1—breast cancer	1.72e-05	0.000484	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—TNF—breast cancer	1.7e-05	0.000481	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—HIST1H2BK—breast cancer	1.7e-05	0.00048	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—HIST1H2BC—breast cancer	1.7e-05	0.00048	CbGpPWpGaD
Flunisolide—CYP3A4—Metapathway biotransformation—CYP1B1—breast cancer	1.69e-05	0.000477	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—RARB—breast cancer	1.69e-05	0.000476	CbGpPWpGaD
Flunisolide—Nausea—Epirubicin—breast cancer	1.67e-05	0.00014	CcSEcCtD
Flunisolide—Vomiting—Doxorubicin—breast cancer	1.65e-05	0.000139	CcSEcCtD
Flunisolide—Rash—Doxorubicin—breast cancer	1.64e-05	0.000138	CcSEcCtD
Flunisolide—Dermatitis—Doxorubicin—breast cancer	1.64e-05	0.000138	CcSEcCtD
Flunisolide—CYP3A4—Biological oxidations—NCOA1—breast cancer	1.64e-05	0.000461	CbGpPWpGaD
Flunisolide—Headache—Doxorubicin—breast cancer	1.63e-05	0.000137	CcSEcCtD
Flunisolide—NR3C1—Gene Expression—RPS7—breast cancer	1.62e-05	0.000456	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—RPS8—breast cancer	1.62e-05	0.000456	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—MED12—breast cancer	1.62e-05	0.000456	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—CYP19A1—breast cancer	1.61e-05	0.000455	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—IL6—breast cancer	1.59e-05	0.000449	CbGpPWpGaD
Flunisolide—CYP3A4—Metapathway biotransformation—CYP19A1—breast cancer	1.59e-05	0.000449	CbGpPWpGaD
Flunisolide—Nausea—Doxorubicin—breast cancer	1.54e-05	0.00013	CcSEcCtD
Flunisolide—CYP3A4—Biological oxidations—COMT—breast cancer	1.5e-05	0.000423	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—GSTP1—breast cancer	1.49e-05	0.000421	CbGpPWpGaD
Flunisolide—NR3C1—Generic Transcription Pathway—ESR1—breast cancer	1.49e-05	0.000419	CbGpPWpGaD
Flunisolide—CYP3A4—Metapathway biotransformation—COMT—breast cancer	1.48e-05	0.000417	CbGpPWpGaD
Flunisolide—CYP3A4—Metapathway biotransformation—GSTP1—breast cancer	1.47e-05	0.000415	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—NOTCH4—breast cancer	1.47e-05	0.000413	CbGpPWpGaD
Flunisolide—NR3C1—Generic Transcription Pathway—NOTCH1—breast cancer	1.44e-05	0.000405	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—HSPA1B—breast cancer	1.4e-05	0.000394	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—IL6—breast cancer	1.38e-05	0.000388	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—GSTM1—breast cancer	1.37e-05	0.000387	CbGpPWpGaD
Flunisolide—CYP3A4—Metapathway biotransformation—GSTM1—breast cancer	1.35e-05	0.000381	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—PGR—breast cancer	1.34e-05	0.000378	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—DNMT1—breast cancer	1.31e-05	0.000371	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—CYP1A1—breast cancer	1.3e-05	0.000367	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—NCOA2—breast cancer	1.29e-05	0.000364	CbGpPWpGaD
Flunisolide—CYP3A4—Metapathway biotransformation—CYP1A1—breast cancer	1.28e-05	0.000362	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—EZH2—breast cancer	1.27e-05	0.000359	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—NOTCH3—breast cancer	1.25e-05	0.000351	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—PARP1—breast cancer	1.25e-05	0.000351	CbGpPWpGaD
Flunisolide—NR3C1—Generic Transcription Pathway—SERPINE1—breast cancer	1.22e-05	0.000345	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—RPS6—breast cancer	1.22e-05	0.000343	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—ESR2—breast cancer	1.18e-05	0.000333	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—NOTCH2—breast cancer	1.12e-05	0.000315	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—NCOA1—breast cancer	1.09e-05	0.000307	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—SYNJ2—breast cancer	1.05e-05	0.000295	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—AR—breast cancer	1.04e-05	0.000294	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—NDUFS3—breast cancer	9.72e-06	0.000274	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—SIRT1—breast cancer	9.5e-06	0.000268	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—SMAD4—breast cancer	9.39e-06	0.000265	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—VDR—breast cancer	9.37e-06	0.000264	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CHST9—breast cancer	9.14e-06	0.000258	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—NCOR1—breast cancer	9.11e-06	0.000257	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—H2AFX—breast cancer	8.88e-06	0.00025	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—COX11—breast cancer	8.67e-06	0.000244	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—ERCC2—breast cancer	8.57e-06	0.000242	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CDA—breast cancer	7.93e-06	0.000224	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—SHMT1—breast cancer	7.93e-06	0.000224	CbGpPWpGaD
Flunisolide—NR3C1—Generic Transcription Pathway—MYC—breast cancer	7.73e-06	0.000218	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—SLCO1B1—breast cancer	7.63e-06	0.000215	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—SLC2A5—breast cancer	7.63e-06	0.000215	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—APRT—breast cancer	7.37e-06	0.000208	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—ESR1—breast cancer	7.16e-06	0.000202	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ESRRA—breast cancer	6.93e-06	0.000195	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ANGPTL4—breast cancer	6.93e-06	0.000195	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—NOTCH1—breast cancer	6.92e-06	0.000195	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GPI—breast cancer	6.57e-06	0.000185	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—HADHB—breast cancer	6.57e-06	0.000185	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ALDH1A1—breast cancer	6.27e-06	0.000177	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ALDH7A1—breast cancer	6.27e-06	0.000177	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—UMPS—breast cancer	6.01e-06	0.000169	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—NME1—breast cancer	6.01e-06	0.000169	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—FHL2—breast cancer	6.01e-06	0.000169	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ADSL—breast cancer	6.01e-06	0.000169	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PHGDH—breast cancer	6.01e-06	0.000169	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—HPSE—breast cancer	5.89e-06	0.000166	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—BRIP1—breast cancer	5.89e-06	0.000166	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—LDHB—breast cancer	5.89e-06	0.000166	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—SERPINE1—breast cancer	5.88e-06	0.000166	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—HMMR—breast cancer	5.58e-06	0.000157	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GSTA3—breast cancer	5.58e-06	0.000157	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ABCC1—breast cancer	5.58e-06	0.000157	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PPARGC1B—breast cancer	5.41e-06	0.000153	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CA9—breast cancer	5.11e-06	0.000144	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GSTA4—breast cancer	5.11e-06	0.000144	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GSTA2—breast cancer	4.98e-06	0.00014	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GPX2—breast cancer	4.98e-06	0.00014	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GPX4—breast cancer	4.92e-06	0.000139	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—SULT1A1—breast cancer	4.92e-06	0.000139	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GSTA1—breast cancer	4.8e-06	0.000135	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—IDH1—breast cancer	4.8e-06	0.000135	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—NAT2—breast cancer	4.75e-06	0.000134	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—MED12—breast cancer	4.16e-06	0.000117	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—DPYD—breast cancer	4.16e-06	0.000117	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ALDOA—breast cancer	4.1e-06	0.000116	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—NCOA3—breast cancer	3.98e-06	0.000112	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—SLC2A2—breast cancer	3.95e-06	0.000111	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CPT1A—breast cancer	3.87e-06	0.000109	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—MTR—breast cancer	3.87e-06	0.000109	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ABCG2—breast cancer	3.87e-06	0.000109	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—MAPK3—breast cancer	3.83e-06	0.000108	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—HPGDS—breast cancer	3.8e-06	0.000107	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—HBA1—breast cancer	3.77e-06	0.000106	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—MYC—breast cancer	3.72e-06	0.000105	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ACHE—breast cancer	3.68e-06	0.000104	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GSTT1—breast cancer	3.68e-06	0.000104	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CYP17A1—breast cancer	3.49e-06	9.83e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PTGS1—breast cancer	3.45e-06	9.73e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ENO1—breast cancer	3.45e-06	9.73e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CYP2D6—breast cancer	3.38e-06	9.54e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—NCOA2—breast cancer	3.32e-06	9.36e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—FASN—breast cancer	3.22e-06	9.08e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—BCHE—breast cancer	3.21e-06	9.04e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—SLC5A5—breast cancer	3.17e-06	8.93e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—NQO1—breast cancer	3.06e-06	8.63e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—SLC2A1—breast cancer	3.06e-06	8.63e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CYP1B1—breast cancer	2.93e-06	8.27e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—HSP90AA1—breast cancer	2.88e-06	8.11e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—NCOA1—breast cancer	2.8e-06	7.89e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—STK11—breast cancer	2.76e-06	7.78e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CYP19A1—breast cancer	2.76e-06	7.78e-05	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—AKT1—breast cancer	2.58e-06	7.28e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—COMT—breast cancer	2.56e-06	7.23e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GSTP1—breast cancer	2.55e-06	7.2e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—HMOX1—breast cancer	2.52e-06	7.1e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ITPR1—breast cancer	2.51e-06	7.08e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ABCB1—breast cancer	2.42e-06	6.81e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—TYMS—breast cancer	2.37e-06	6.69e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—NCOR1—breast cancer	2.35e-06	6.61e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GSTM1—breast cancer	2.35e-06	6.61e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PLA2G4A—breast cancer	2.35e-06	6.61e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GPX1—breast cancer	2.25e-06	6.33e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CYP1A1—breast cancer	2.22e-06	6.27e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ERCC2—breast cancer	2.2e-06	6.22e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—MTHFR—breast cancer	2.07e-06	5.84e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CAV1—breast cancer	1.91e-06	5.39e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PIK3CG—breast cancer	1.74e-06	4.91e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PIK3CD—breast cancer	1.53e-06	4.32e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ALB—breast cancer	1.51e-06	4.26e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—NOS3—breast cancer	1.45e-06	4.08e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PIK3CB—breast cancer	1.33e-06	3.76e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PTGS2—breast cancer	1.32e-06	3.73e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PTEN—breast cancer	1.15e-06	3.25e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PIK3CA—breast cancer	8.13e-07	2.29e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—AKT1—breast cancer	6.64e-07	1.87e-05	CbGpPWpGaD
